 Connection
Nancy Rusch to Retina
This is a "connection" page, showing publications Nancy Rusch has written about Retina.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.549 |
|
|
|
-
Shahror RA, Zaman B, Chuesiang P, Wild M, Shosha E, Leung YK, Mu S, Rusch NJ, Fouda AY. CD5L promotes efferocytosis and resolution of retinal ischemic injury. Cell Death Dis. 2026 Apr 20; 17(1).
Score: 0.229
-
Mitchell CD, Morris CA, Wild M, Cunningham A, Chuesiang P, Mohammed AA, Nagalo BM, Rusch NJ, Fouda AY, Shosha E. HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis. Acta Pharmacol Sin. 2026 Apr; 47(4):1058-1069.
Score: 0.220
-
Shahror RA, Shosha E, Morris C, Wild M, Mu S, Csanyi G, Boerma M, Rusch NJ, Fouda AY. Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury. J Neuroinflammation. 2024 Jul 12; 21(1):170.
Score: 0.051
-
Shahror RA, Morris CA, Mohammed AA, Wild M, Zaman B, Mitchell CD, Phillips PH, Rusch NJ, Shosha E, Fouda AY. Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions. J Neuroinflammation. 2024 Mar 07; 21(1):65.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|